Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
Clinical trial NCT04460001 · UNKNOWN
Trial details
- NCT number
- NCT04460001
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2021-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.